Protective Effect and Its Mechanism Analysis of Baihe Wuyao Decoction on Treatment of Type 1 Diabetes Mellitus and Associated Hepatic Injury

XUE Lihui; SONG Hongyu; GAO Qi; LI Shuang; ZHAO Chenlei; BAI Yang; ZHANG Bonan; QI Yajuan

doi:10.13386/j.issn1002-0306.2021050136

Volume 43 Issue 2

Jan. 2022

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2022 > 43(2): 376-383. > DOI: 10.13386/j.issn1002-0306.2021050136

XUE Lihui, SONG Hongyu, GAO Qi, et al. Protective Effect and Its Mechanism Analysis of Baihe Wuyao Decoction on Treatment of Type 1 Diabetes Mellitus and Associated Hepatic Injury[J]. Science and Technology of Food Industry, 2022, 43(2): 376−383. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021050136.

Citation:

PDF (2551 KB)

Protective Effect and Its Mechanism Analysis of Baihe Wuyao Decoction on Treatment of Type 1 Diabetes Mellitus and Associated Hepatic Injury

XUE Lihui^1,,
SONG Hongyu¹,
GAO Qi¹,
LI Shuang¹,
ZHAO Chenlei¹,
BAI Yang²,
ZHANG Bonan^{2, 3, 4, ,},
QI Yajuan^{2, 3, 4, ,}

1.
Department of Pharmacy, North China University of Science and Technology, Tangshan 063210, China
2.
School of Basic Medical Sciences, North China University of Science and Technology, Tangshan 063210, China
3.
Tangshan Key Laboratory of New Drug Basic Research, Tangshan 063210, China
4.
Hebei Key Laboratory for Chronic Diseases, Tangshan 063210, China

More Information

Received Date: May 18, 2021
Available Online: November 21, 2021

Graphical Abstract

Abstract

Abstract

Objective: To investigate the protective effect of Baihe Wuyao decoction (BWD) on mice with type 1 diabetes mellitus (T1DM) and liver damage, and to reveal its underlying mechanism. Methods: Ten of 70 mice were randomly selected as the blank group, and the rest were induced with intra-peritoneally (ip) streptozotocin (STZ) to induce T1DM. After successful modeling, the mice were randomly divided into 6 groups: Model group, positive control group and BWD groups (15, 5, 2.5, 1.25 g·kg⁻¹·d⁻¹). The mice in each group were given continuous administration for 6 weeks. The contents of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the serum of mice were measured, and the contents of superoxidedismutase (SOD) and malonaldehyde (MDA) in liver tissue homogenate were detected. The pathological changes of mouse liver were observed. The expression of Protein kinase B (AKT) in mouse liver was detected, the mRNA level of manganese superoxide dismutase (Mn-SOD) and nitric oxide synthase (iNOS), inflammatory factors including tumor necrosis factor (TNF-α), nuclear factor-κB (NF-κB), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), apoptosis factors including B-cell lymphoma-2 (Bcl2), Bcl2-associated X protein (Bax), Caspase 3 (CASP3) were measured. Results: BWD exhibited a good hepatic protection with ameliorating hepatic pathological morphology in T1DM mice. Compared with the model group, the levels of ALT and AST in each dose group were significantly reduced (P<0.01, P<0.05), and the effect of the low 1 dose group was more obvious. The low 1 dose of BWD could significantly up-regulate p-AKT/AKT(P<0.05), low dose 1 could significantly down-regulate MDA, iNOS, and up-regulate SOD and Mn-SOD content(P<0.01, P<0.05). Comparing with the model group, the ratio of Bcl2/Bax at the low dose increased significantly, Bax and CASP3 were down-regulated, the low dose significantly reduced the expression of TNF-α, NF-κB, IL-1β, IL-6 and IL-8 at the gene level (P<0.01, P<0.05). Conclusion: The BWD would have a good hepatic protective effect during T1DM, which underlying mechanisms through improving insulin resistance and suppresses oxidative stress, apoptosis, inflammation and promotion of cell proliferation.
- liver injury,
- inflammation,
- mechanism,
- Baihe Wuyao decoction

FullText(HTML)

References (31)

References

[1]	LIANG T T, ZHANG Q, SUN W X, et al. Zinc treatment prevents type 1 diabetes-induced hepatic oxidative damage, endoplasmic reticulum stress, and cell death, and even prevents possible steatohepatitis in the OVE26 mouse model: Important role of metallothionein[J]. Toxicol Lett,2015,20(2):24−114.
[2]	WANG W P, M JOHN, P KIMBERLY, et al. Hepatoprotective activity of easter lily(Lilium longiflorum Thunb.) bulb extracts[J]. Journal of Agricultural and Food Chemistry,2015,40(44):698−722.
[3]	S VAROL, K SEDAT, S ERHAN, et al. Investigation of endoplasmic reticulum stress and sonic hedgehog pathway in diabetic liver injury in mice[J]. Life Science,2020,10(8):117−156.
[4]	罗良胜, 屈磊磊, 杨丽英, 等. 紫茉莉对高血糖模型小鼠降血糖作用研究[J]. 云南中医中药杂志,2009,30(4):51−53. [LUO L S, QU L L, YANG L Y, et al. Study on hypoglycemic effect of Mirabilis on hyperglycemia model mice[J]. Yunnan Journal of Traditional Chinese Medicine and Materia Medica,2009,30(4):51−53.
[5]	梁燕, 王岳飞, 谢争珍, 等. 茶桑混合袋泡茶降血糖作用的实验研究[J]. 茶叶科学,2008,12(5):358−362. [LIANG Y, WANG Y F, XIE Z Z, et al. Experimental study on hypoglycemic effect of tea-mulberry mixed teabag[J]. Journal of Tea Science,2008,12(5):358−362. doi: 10.3969/j.issn.1000-369X.2008.05.008
[6]	ZHANG H Y, WANG H L, ZHONG G Y, et al. Molecular mechanism and research progress on pharmacology of traditional Chinese medicine in liver injury[J]. Pharmaceutical Biology,2018,10(1):594−611.
[7]	田硕, 苗明三, 熊维政, 等. 2020年版《中国药典》(一部)药材和饮片的外用功能及应用分析[J]. 中国实验方剂学杂志,2021,27(8):161−167. [TIAN S, MIAO M S, XIONG W Z, et al. Analysis of the external function and application of medicinal materials and decoction pieces in the 2020 Chinese Pharmacopoeia (Part 1)[J]. Chinese Journal of Experimental Traditional Medical Formulae,2021,27(8):161−167.
[8]	LUO L M, QIN L, ZHAN J H, et al. Study on effects of total saponins from Lilii Bulbus on proliferation, apoptosis, invasion and metastasis of lung cancer cells and its preliminary mechanism[J]. China Journal of Chinese Materia Medica,2018,18(22):4498−4505.
[9]	刘智衡. 百合乌药汤合平胃散加减治疗浅表性胃炎34例临床疗效观察[J]. 中医临床研究,2016,8(8):64−66. [LIU Z H. Clinical observation on 34 cases of superficial gastritis treated with Baihewuyao decoction and Pingwei powder[J]. Clinical Journal of Chinese Medicine,2016,8(8):64−66. doi: 10.3969/j.issn.1674-7860.2016.08.034
[10]	QING L, A J HOON, K S BEOM, et al. Sesquiterpene lactones from the roots of Lindera strychnifolia[J]. Phytochemistry,2012,20(15):89−112.
[11]	SUN X, GAO R L, XIONG Y K, et al. Antitumor and immunomodulatory effects of a water-soluble polysaccharide from Lilii Bulbus in mice[J]. Carbohydrate Polymers,2013,35(18):429−543.
[12]	LUO Y B, LIU M, YAO X J, et al. Total alkaloids from Radix Linderae prevent the production of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 cells by suppressing NF-kappaB and MAPKs activation[J]. Cytokine,2009,15(1):100−104.
[13]	邢梦雨, 田崇梅, 夏道宗. 乌药化学成分及药理作用研究进展[J]. 天然产物研究与开发,2017,29(12):2147−2151. [XING Y M, TIAN C M, XIA D Z, et al. Review on chemical constituents and pharmacological effects of Lindera aggregata Kosterm[J]. Nat Prod Res Dev,2017,29(12):2147−2151.
[14]	来伟旗, 朱染枫, 陈建国, 等. 乌药的毒性研究[J]. 职业与健康,2003(12):78−80. [LAI Q W, ZHU R F, CHEN J G, et al. Study on the toxicity of Lindera aggregate (Sims) kosterm[J]. Occupation and Health,2003(12):78−80. doi: 10.3969/j.issn.1004-1257.2003.12.042
[15]	EBTSAM M A, MARWA A A, DOAA H, et al. Assessment of the hepatoprotective effect of developed lipid-polymer hybrid nanoparticles(LPHNPs) encapsulating naturally extracted β-Sitosterol against CCl4 induced hepatotoxicity in rats[J]. Scientific Reports,2019,9(11):1083−1096.
[16]	WANG J W, CHEN X Y, HU P Y, et al. Effects of Linderae radix extracts on a rat model of alcoholic liver injury[J]. Experimental and Therapeutic Medicine,2016,11(6):2185−2192. doi: 10.3892/etm.2016.3244
[17]	GAN L S, ZHENG Y L, MO J X, et al. Sesquiterpene lactones from the root tubers of Lindera aggregata[J]. Journal of Natural Products,2009,8(8):501−1497.
[18]	CHEN Y J, LI R F, HU N, et al. Baihe Wuyao decoction ameliorates CCl₄-induced chronic liver injury and liver fibrosis in mice through blocking TGF-β1/Smad2/3 signaling, anti-inflammation and anti-oxidation effects[J]. Journal of Ethnopharmacology,2020,23(10):113−227.
[19]	LIM D W, KIM H, LEE S J, et al. Jwa kum whan attenuates nonalcoholic fatty liver disease by modulating glucose metabolism and the insulin signaling pathway[J]. Evidence-Based Complementary and Alternative Medicine,2019:4589810.
[20]	A MAHMOOD, R MOHAMMAD, M EBRAHIM, et al. Urtica dioica and Lamium album decrease glycogen synthase kinase-3 beta and increase K-Ras in diabetic rats[J]. Journal of Pharmacopuncture,2019,14(4):248−252.
[21]	LIU F, ZHANG J, QIAN J, et al. Emodin alleviates CCl4-induced liver fibrosis by suppressing epithelial-mesenchymal transition and transforming growth factor-β1 in rats[J]. Molecular Medicine Reports,2018,18(3):3262−3270.
[22]	B AURÈLE, E JENNIFER L. An intimate relationship between ROS and insulin signalling: Implications for antioxidant treatment of fatty liver disease[J]. International Journal of Cell Biology,2014,15(10):119−153.
[23]	G RAJEEV, S MONIL, F ABUL FAIZ. Glutathione peroxidase activity in obese and nonobese diabetic patients and role of hyperglycemia in oxidative stress[J]. Journal of Mid-Life Health,2011,8(2):6−72.
[24]	LIU W, JING Z T, XUE C R, et al. PI3K/AKT inhibitors aggravate death receptor-mediated hepatocyte apoptosis and liver injury[J]. Toxicology and Applied Pharmacology,2019,19(10):714−729.
[25]	LIU Y E, TONG C C, TANG Y S, et al. Tanshinone IIA alleviates blast-induced inflammation, oxidative stress and apoptosis in mice partly by inhibiting the PI3K/AKT/FoxO1 signaling pathway[J]. Free Radical Biology & Medicine,2020,23(18):52−60.
[26]	R FARZAD, A FERESHTEH, A AMIR, et al. Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K/AKT and NF-κB signaling pathways[J]. Life Science,2020,15(6):117−150.
[27]	J Y KIM MULLER, Y J R KIM, J FAN, et al. FoxO1 deacetylation decreases fatty acid oxidation in β-cells and sustains insulin secretion in diabetes[J]. The Journal of Biological Chemistry,2016,21(19):72−101.
[28]	T MOLDOVEANU, P E CZABOTAR. BAX, BAK, and BOK: A coming of age for the BCL-2 family effector proteins[J]. Cold Spring Harbor Perspectives in Biology,2020,12(4):56−60.
[29]	E FRANK. BCL-2 proteins and apoptosis: Recent insights and unknowns[J]. Biochemical and Biophysical Research Communications,2018,500(1):26−34. doi: 10.1016/j.bbrc.2017.06.190
[30]	AG PORTER, R U JÄNICKE. Emerging roles of caspase-3 in apoptosis[J]. Cell Death and Differentiation,1999,6(2):99−104. doi: 10.1038/sj.cdd.4400476
[31]	M LÉVEILLÉ, ESTALL J L. Mitochondrial dysfunction in the transition from NASH to HCC[J]. Metabolites,2019,9(10):233. doi: 10.3390/metabo9100233

Supplements (0)

Cited By

Cited by

Periodical cited type(4)

1.	谭思远，阮兴阳，王园莉，惠和平，陈月星，范娜. 气相色谱-质谱/选择离子监测模式检测食用菌多糖中单糖组成方法的建立与质谱解析. 食品安全质量检测学报. 2025(02): 196-205 .
2.	王帅，孔博洋，李婷，贾小艳，肖红，位张坤，张继，王俊龙. 微波处理对刺槐豆胶多糖结构特征的影响. 中国食品添加剂. 2024(01): 87-98 .
3.	张弘弛，刘瑞，巴德方，李慧，杨阳，周凤. 恒山黄芪~1H-NMR指纹图谱的研究. 食品工业科技. 2022(01): 47-55 . 本站查看
4.	任一杰，赵小亮，王宝忠，向紫骏，杨超福，王海利，马君义，张伟杰. 油橄榄叶多糖的提取工艺优化及其理化性质和抗氧化活性. 食品工业科技. 2022(23): 245-251 . 本站查看